Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer

被引:59
作者
Chajon, Enrique [1 ]
Dumas, Isabelle [1 ]
Touleimat, Mahmoud [1 ]
Magne, Nicolas [1 ]
Coulot, Jeremy [1 ]
Verstraet, Rodolfe [1 ]
Lefkopoulos, Dimitri [1 ]
Haie-Meder, Christine [1 ]
机构
[1] Inst Gustave Roussy, Dept Radiotherapy, Brachytherapy Serv, F-94805 Villejuif, France
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期
关键词
brachytherapy; cervical cancer; inverse planning; pulsed-dose rate;
D O I
10.1016/j.ijrobp.2007.07.2321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to evaluate the inverse planning simulated annealing (IPSA) software for the optimization of dose distribution in patients with cervix carcinoma treated with MRI-based pulsed-dose rate intracavitary brachytherapy. Methods and Materials: Thirty patients treated with a technique using a customized vaginal mold were selected. Dose-volume parameters obtained using the IPSA method were compared with the classic manual optimization method (MOM). Target volumes and organs at risk were delineated according to the Gynecological Brachytherapy Group/European Society for Therapeutic Radiology and Oncology recommendations. Because the pulsed dose rate program was based on clinical experience with low dose rate, dwell time values were required to be as homogeneous as possible. To achieve this goal, different modifications of the IPSA program were applied. Results: The first dose distribution calculated by the IPSA algorithm proposed a heterogeneous distribution of dwell time positions. The mean D90, D100, and V100 calculated with both methods did not differ significantly when the constraints were applied. For the bladder, doses calculated at the ICRU reference point derived from the MOM differed significantly from the doses calculated by the IPSA method (mean, 58.4 vs. 55 Gy respectively; p = 0.0001). For the rectum, the doses calculated at the ICRU reference point were also significantly lower with the IPSA method. Conclusions: The inverse planning method provided fast and automatic solutions for the optimization of dose distribution. However, the straightforward use of IPSA generated significant heterogeneity in dwell time values. Caution is therefore recommended in the use of inverse optimization tools with clinical relevance study of new dosimetric rules. (C) 2007 Elsevier Inc.
引用
收藏
页码:955 / 961
页数:7
相关论文
共 16 条
  • [1] A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy
    Baltas, D
    Kolotas, C
    Geramani, K
    Mould, RF
    Ioannidis, G
    Kekchidi, M
    Zamboglou, N
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (02): : 515 - 524
  • [2] Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies
    Barillot, I
    Horiot, JC
    Maingon, P
    Truc, G
    Chaplain, G
    Comte, J
    Brenier, JP
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01): : 189 - 200
  • [3] DOSE-VOLUME ANALYSIS AND THE PREVENTION OF RADIATION SEQUELAE IN CERVICAL-CANCER
    CROOK, JM
    ESCHE, BA
    CHAPLAIN, G
    ISTURIZ, J
    SENTENAC, I
    HORIOT, JC
    [J]. RADIOTHERAPY AND ONCOLOGY, 1987, 8 (04) : 321 - 332
  • [4] 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer
    DeWitt, KD
    Hsu, ICJ
    Speight, J
    Weinberg, VK
    Lessard, E
    Pouliot, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (04): : 1270 - 1274
  • [5] GERBAULET A, 1997, RAD ONCOLOGY GYNECOL, P198
  • [6] GERBAULET A, 1992, B CANC RADIOTHER, V79, P107
  • [7] Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
    Haie-Meder, C
    Pötter, R
    Van Limbergen, E
    Briot, E
    De Brabandere, M
    Dimopoulos, J
    Dumas, I
    Hellebust, TP
    Kirisits, C
    Lang, SF
    Muschitz, S
    Nevinson, J
    Nulens, A
    Petrow, P
    Wachter-Gerstner, N
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) : 235 - 245
  • [8] Haie-Meder C, 2003, Cancer Radiother, V7, P42, DOI 10.1016/S1278-3218(02)00282-2
  • [9] International Commission on Radiation Units and Measurements, 1985, 38 ICRU
  • [10] Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate
    Lachance, B
    Béliveau-Nadeau, D
    Lessard, É
    Chrétien, M
    Hsu, ICJ
    Pouliot, J
    Beaulieu, L
    Vigneault, É
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01): : 86 - 100